Energy Efficiency, GHG Emissions, Industrial  -  November 27, 2023

Aurisco Sets 2027 Goals

Aurisco Pharmaceutical Co., Ltd., a USFDA-inspected cGMP generic API manufacturer and CRDMO for modified amidites, oligonucleotides and peptides, announced it plans to achieve carbon neutrality by 2027 and zero emissions by 2030.

The company also plans to increase its total energy consumption from renewable energy sources to over 95% by 2030, according to a statement.

During the next two years, Aurisco plans to develop over 10,000 square meters of solar energy projects and operate 100% on green electricity by 2025.

Additional plans by the company include lowering energy consumption and emissions in industrial processes through equipment upgrades and chemical process optimization.

Aurisco will regularly publish carbon emissions data and report its progress in reducing emissions, submit an annual climate action report and be audited by a third party, establish partnerships with domestic and overseas enterprises and organizations to jointly promote achieving the carbon neutrality targets,and improve supplier management, and promote green energy use.

Share this valuable information with your colleagues using the buttons below: